Wyss Institute, Harvard University
Donald E. Ingber, M.D., Ph.D. is the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He received his B.A., M.A., M.Phil., M.D. and Ph.D. from Yale University. Ingber is a pioneer in the field of biologically inspired engineering, and at the Wyss Institute, he currently leads scientific and engineering teams that cross a broad range of disciplines to develop breakthrough bioinspired technologies to advance healthcare and to improve sustainability. His work has led to major advances in mechanobiology, tumor angiogenesis, tissue engineering, systems biology, nanobiotechnology, and translational medicine, with his most recent pioneering contributions being the development of human Organ-on-Chips as replacements for animal testing and multiplexed electrochemical sensors for medical diagnostics. Through his work, Ingber has helped to break down boundaries between science, art and design, and has made great strides in translating his innovations into commercial products with many now either in clinical trials or currently being sold. He has authored more than 500 publications and over 170 U.S. patents, founded 7 companies, and has been a guest speaker at more than 550 events internationally. Ingber is a member of the National Academy of Medicine, National Academy of Engineering, National Academy of Inventors, American Institute for Medical and Biological Engineering, and the American Academy of Arts and Sciences. He also was listed among the Top 20 Translational Researchers in 2012, 2019, and 2020 (Nature Biotechnology).